Latest News & Features
Unified Patent Court
The Unified Patent Court’s first decisions from the first instance divisions—with healthcare-related subject matter predominating—have been made within weeks of the first anniversary of the UPC opening for litigation cases. Darren Smyth of EIP examines the details. 3 September 2024
Careers
Firm welcomes veteran litigator from Baker McKenzie and transactional lawyer from Covington & Burling | Pair specialise in global IP litigation and strategic transactions. 3 September 2024
Europe
Court grants access to test case documents after eight months | Mathys & Squire applied for access to challenge UPC's transparency | Firm says "significant concerns" remain about the court's commitment to transparency and open justice. 30 August 2024
Americas
Regeneron accused the Swiss pharma company of infringing a slew of patents related to Eylea and violating the BPCIA | Suit alleges that Sandoz failed to provide critical information during the approval process for its newly FDA-approved biosimilar | Sandoz “forced” Regeneron to guess which patents might be infringed. 29 August 2024
Americas
If adopted, the pending rule would reshape litigation strategy and offer patent defendants a valuable tool, say Kristen Lovin and Niall Frizzell of Keker, Van Nest & Peters 29 August 2024
Careers
Former Mayer Brown partner joins White & Case, bringing experience with high-tech companies | New hire specialisms include medical devices, pharmaceuticals and chemical products. 29 August 2024
Americas
Biopharma firm sues CSPC for allegedly infringing Onivyde patent issued in August | Suit follows complaint in April asserting eight patents against Conjupro’s product. 27 August 2024
Americas
Federal magistrate proposes awarding Abbott millions of dollars from 85 companies and individuals for selling unauthorised diabetes test strips | Judge advises a permanent injunction in almost a decade old trademark case. 27 August 2024
Americas
Judges will not rehear safe harbour case between Edwards and Meril | Medtech company said court’s precedent ‘distorts the market’ for patented products. 22 August 2024
Americas
FTC backs FDA's proposals to streamline approval process for interchangeable biosimilars | Move aims to lower prescription drug costs and expand access to critical treatments | FTC emphasises the new guidance could create competition in the biologics market and save US healthcare billions of dollars. 22 August 2024